Average Co-Inventor Count = 5.60
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nestec S.a. (6 from 2,370 patents)
2. Societe Des Produits Nestle S.a. (4 from 1,150 patents)
3. Prometheus Laboratories Inc. (1 from 22 patents)
4. Pierian Holdings, Inc. (1 from 3 patents)
5. Diatech Holdings, Inc. (1 from 1 patent)
6. Prometheus Biosciences, Inc. (14 patents)
13 patents:
1. 10697967 - Methods for predicting response of triple-negative breast cancer to therapy
2. 10527622 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
3. 10473640 - Drug selection for gastric cancer therapy using antibody-based arrays
4. 10436786 - Methods for detecting truncated receptors using antibody-based arrays
5. 9726669 - Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy
6. 9575066 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
7. 9535052 - Apparatus and method for isolating leukocytes and tumor cells by filtration
8. 9488654 - Methods for predicting response of triple-negative breast cancer to therapy
9. 9285369 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
10. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays
11. 8658388 - Antibody-based arrays for detecting multiple signal transducers in rate circulating cells
12. 8609349 - Drug selection for breast cancer therapy using antibody-based arrays
13. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays